Live attenuated influenza vaccine use and safety in children and adults with asthma.

CONCLUSION: LAIV use in asthma was mostly in persons with intermittent or mild persistent asthma. LAIV was not associated with an increased risk of medically attended respiratory adverse events.
PMID: 28390584 [PubMed - in process]

Source: Annals of Allergy, Asthma and Immunology - April 1, 2017 Category: Allergy & Immunology Authors: Duffy J, Lewis M, Harrington T, Baxter R, Belongia EA, Jackson LA, Jacobsen SJ, Lee GM, Naleway AL, Nordin J, Daley MF, Vaccine Safety Datalink Tags: Ann Allergy Asthma Immunol Source Type: research